CoChat

Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Pregnancy-associated malaria is caused by Plasmodium falciparum malaria parasites binding specifically to chondroitin sulfate A in the placenta. This sequestration of parasites is a major cause of low birth weight in infants and anemia in the mothers. VAR2CSA, a polymorphic multi-domain protein of the PfEMP1 family, is the main parasite ligand for CSA binding, and identification of protective antibody epitopes is essential for VAR2CSA vaccine development. Attempts to determine the crystallographic structures of VAR2CSA or its domains have not been successful yet. In this study, we propose 3D models for each of the VAR2CSA DBL domains and we show that regions in the fold of VAR2CSA inter-domain 2 and a PfEMP1 CIDR domain seem to be homologous to the EBA-175 and Pk alpha-DBL fold. This suggests that ID2 could be a functional domain. We also identify regions of VAR2CSA present on the surface of native VAR2CSA by comparing reactivity of plasma containing anti-VAR2CSA antibodies in peptide array experiments before and after incubation with native VAR2CSA. By this method we identify conserved VAR2CSA regions targeted by antibodies that react with the native molecule expressed on infected erythrocytes. By mapping the data onto the DBL models we present evidence suggesting that the S1+S2 DBL sub-domains are generally surface-exposed in most domains, whereas the S3 sub-domains are less exposed in native VAR2CSA. These results comprise an important step towards understanding the structure of VAR2CSA on the surface of CSA-binding infected erythrocytes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.0040042

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structure Models of the VAR2CSA DBL Domains The experimental structures of the template EBA-175 and Pkα-DBL domains are shown in the first row, and DBL models are shown in the middle and last rows. Sub-domains 1–3 of Pkα-DBL (Pka-DBL) are colored in blue, green, and yellow, respectively. Cysteines in all domains are highlighted in red. Disulfide bonds in templates are numbered according to occurrence in the sequences and corresponding cysteine pairs in the models are numbered with respect to the template numbering.
Figure 1 Structure Models of the VAR2CSA DBL Domains The experimental structures of the template EBA-175 and Pkα-DBL domains are shown in the first row, and DBL models are shown in the middle and last rows. Sub-domains 1–3 of Pkα-DBL (Pka-DBL) are colored in blue, green, and yellow, respectively. Cysteines in all domains are highlighted in red. Disulfide bonds in templates are numbered according to occurrence in the sequences and corresponding cysteine pairs in the models are numbered with respect to the template numbering.CC BY · PubMed Central
Figure 2 A Structural Alignment of the Template Structures EBA-175 F1 and F2 and Pkα-DBL and the Six VAR2CSA DBL Models Vertical color bars denote positions of stabilizing residues in template structures. Blue bars denote cysteines forming disulfide bonds, green bars denote buried hydrophobic residues, orange bars denote helix capping residues, and red bars denote buried polar/charged residues. The location of sub-domains S1–S3 are marked by horizontal black bars, and regions of missing structural information in the template structures are marked by black arrowheads. Residues involved in GAG binding of EBA-175 DBL domains or DARC receptor binding of Pkα-DBL are marked with red letters. EBA-175 residues involved in dimerization are marked in blue letters.
Figure 2 A Structural Alignment of the Template Structures EBA-175 F1 and F2 and Pkα-DBL and the Six VAR2CSA DBL Models Vertical color bars denote positions of stabilizing residues in template structures. Blue bars denote cysteines forming disulfide bonds, green bars denote buried hydrophobic residues, orange bars denote helix capping residues, and red bars denote buried polar/charged residues. The location of sub-domains S1–S3 are marked by horizontal black bars, and regions of missing structural information in the template structures are marked by black arrowheads. Residues involved in GAG binding of EBA-175 DBL domains or DARC receptor binding of Pkα-DBL are marked with red letters. EBA-175 residues involved in dimerization are marked in blue letters.CC BY · PubMed Central
Figure 3 Modeled Regions of ID2 and CIDR Domains The S3 domain of the template EBA-175 F2 is shown in white. Cysteines in the models are highlighted in red. (A) The model of the VAR2CSA ID2 domain superimposed in yellow on the EBA-175 F2. (B) Similar to (A) except showing only the S3 domain. (C) Model of a CIDR domain.
Figure 3 Modeled Regions of ID2 and CIDR Domains The S3 domain of the template EBA-175 F2 is shown in white. Cysteines in the models are highlighted in red. (A) The model of the VAR2CSA ID2 domain superimposed in yellow on the EBA-175 F2. (B) Similar to (A) except showing only the S3 domain. (C) Model of a CIDR domain.CC BY · PubMed Central
Figure 4 Mapping of Surface-Exposed Antibody-Reactive Regions onto the Model of the DBL6 Domain The color intensity denotes the level of antibody depletion when VAR2CSA containing plasma is incubated with parasites expressing native VAR2CSA. The following plasma and parasite combinations were used for the depletion experiments. (A) Human plasma pool 1 depleted with 3D7 parasites. (B) Human plasma pool 2 depleted with 3D7 parasites. (C) Human plasma pool 2 depleted with FCR3 parasites. (D) Rabbit plasma pool depleted with 3D7 parasites.
Figure 4 Mapping of Surface-Exposed Antibody-Reactive Regions onto the Model of the DBL6 Domain The color intensity denotes the level of antibody depletion when VAR2CSA containing plasma is incubated with parasites expressing native VAR2CSA. The following plasma and parasite combinations were used for the depletion experiments. (A) Human plasma pool 1 depleted with 3D7 parasites. (B) Human plasma pool 2 depleted with 3D7 parasites. (C) Human plasma pool 2 depleted with FCR3 parasites. (D) Rabbit plasma pool depleted with 3D7 parasites.CC BY · PubMed Central
Figure 5 Areas Predicted to be Targeted by Surface-Reactive Antibodies on the Six VAR2CSA DBL Domains The highlighted regions were defined on the basis of the results of several experiments where anti-VAR2CSA antibody containing plasma was incubated with parasites expressing native VAR2CSA. Residues with consensus DVs > 1 which are conserved in sequences of VAR2CSA are highlighted in blue, and variable residues with consensus DVs>1 are highlighted in green. See text for details. The positions of DBL3 and DBL5 peptides (P62 and P63 respectively) used for affinity purifying IgG (see Figure 8) are marked with black arrows.
Figure 5 Areas Predicted to be Targeted by Surface-Reactive Antibodies on the Six VAR2CSA DBL Domains The highlighted regions were defined on the basis of the results of several experiments where anti-VAR2CSA antibody containing plasma was incubated with parasites expressing native VAR2CSA. Residues with consensus DVs > 1 which are conserved in sequences of VAR2CSA are highlighted in blue, and variable residues with consensus DVs>1 are highlighted in green. See text for details. The positions of DBL3 and DBL5 peptides (P62 and P63 respectively) used for affinity purifying IgG (see Figure 8) are marked with black arrows.CC BY · PubMed Central
Figure 6 VAR2CSA DBL4 Regions Predicted to be Targeted by Surface-Reactive Antibodies The plot is similar to Figure 4, except viewed from the reverse side.
Figure 6 VAR2CSA DBL4 Regions Predicted to be Targeted by Surface-Reactive Antibodies The plot is similar to Figure 4, except viewed from the reverse side.CC BY · PubMed Central
Figure 7 A Matrix Showing the Level of Cross-Reactive Antibody Targets between 22 Placental VAR2CSA DBL3 Variants Produced in Baculovirus-Infected Insect Cells Cross-reactivity was determined by competition ELISA using a Tanzanian female plasma pool with a high titer of VAR2CSA-specific antibodies. Responses with the same protein as the competing and coating antigen are shown in the diagonal. Blanks with no square are protein combinations not tested. The identity of the various DBL3 proteins corresponds to the nomenclature used in the published multiple sequence alignment [18]. Control proteins included a DBL5 VAR2CSA protein and a non-VAR2CSA DBL domain (PFD1235w).
Figure 7 A Matrix Showing the Level of Cross-Reactive Antibody Targets between 22 Placental VAR2CSA DBL3 Variants Produced in Baculovirus-Infected Insect Cells Cross-reactivity was determined by competition ELISA using a Tanzanian female plasma pool with a high titer of VAR2CSA-specific antibodies. Responses with the same protein as the competing and coating antigen are shown in the diagonal. Blanks with no square are protein combinations not tested. The identity of the various DBL3 proteins corresponds to the nomenclature used in the published multiple sequence alignment [18]. Control proteins included a DBL5 VAR2CSA protein and a non-VAR2CSA DBL domain (PFD1235w).CC BY · PubMed Central
Figure 8 Surface Reactivity (Fitch FL1) of Rabbit Antibodies Targeting Conserved VAR2CSA Regions Rabbit antibodies were affinity purified on peptides (P62 and P63; see Figure 5 for details) and tested for reactivity with IE expressing VAR2CSA. The parasite lines FCR3CSA (A) and 3D7CSA (B) IE were used. The following antibodies were used: grey, IgG control; red, VAR2CSA-specific rabbit pool; blue, P63 (DBL5)-specific antibodies; green, P62 (DBL3)-specific antibodies. For FCR3, the number of cells staining positive with the VAR2CSA pool, P63 and P62 were 97%, 56%, and 48%, respectively. For 3D7, 85%, 7%, and 6% of the cells were positive.
Figure 8 Surface Reactivity (Fitch FL1) of Rabbit Antibodies Targeting Conserved VAR2CSA Regions Rabbit antibodies were affinity purified on peptides (P62 and P63; see Figure 5 for details) and tested for reactivity with IE expressing VAR2CSA. The parasite lines FCR3CSA (A) and 3D7CSA (B) IE were used. The following antibodies were used: grey, IgG control; red, VAR2CSA-specific rabbit pool; blue, P63 (DBL5)-specific antibodies; green, P62 (DBL3)-specific antibodies. For FCR3, the number of cells staining positive with the VAR2CSA pool, P63 and P62 were 97%, 56%, and 48%, respectively. For 3D7, 85%, 7%, and 6% of the cells were positive.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 79

Metadata

Authors
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A.
Affiliations
  • Technical University of Denmark (DK)
  • University of Copenhagen (DK)
Corresponding author
Salanti, Ali
Venue
PLoS Pathogens
Published
2008-02-15
Volume
4
Issue
2
Pages
e42
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2049001957
Cited by
79
References
43
Citations by year
2025: 1 · 2023: 4 · 2022: 3 · 2021: 6 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 6 · 2013: 4 · 2012: 6
FWCI
11.21
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
Keywords
VAR2CSA, malaria in pregnancy, Plasmodium falciparum, chondroitin sulfate A, PfEMP1, DBL domains, EBA-175, antibody epitopes, 3D structural model, malaria vaccine, infected erythrocytes, low birth weight
MeSH terms
Adult, Animals, Antigens, Protozoan, Chondroitin Sulfates, Erythrocytes, Female, Humans, Male, Models, Molecular, Plasmodium falciparum, Pregnancy, Protein Conformation, Rabbits, Recombinant Proteins, Genetic Variation, Pregnancy Complications, Parasitic, Protozoan Proteins, Malaria, Falciparum, Epitope Mapping

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA. https://app.cochat.ai/papers/10.1371/journal.ppat.0040042
The paper
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008). Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.0040042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.